Paul K. Audhya, CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 3,075 shares at $14.48 ($45K) on 2025-11-18, disclosed to the SEC on 2025-11-19.
Seasonal sale ($45k) by CHIEF MEDICAL OFFICER — this insider has traded KALV in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KALV | SELL | 2026-05-19 | $28K | — | Filing → |
| KALV | SELL | 2026-04-20 | $54K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |